Regarding potential confounding by indication related to an obesity diagnosis, the number of outcomes in individuals diagnosed with obesity according to the registers is too low to carry out a meaningful subgroup analysis
Studies suggest tirzepatide may cause slightly less nausea, vomiting, and reflux for some people, even though both medications share similar side-effect profiles
Liraglutide (Saxenda), an earlier GLP1 medication, uses a similar approach but has a shorter half-life of about 13 hours, requiring daily injection
If you or a loved one suffered severe health problems after taking GLP-1 receptor agonist drugs such as Ozempic, Wegovy, Mounjaro, Rybelsus, or Trulicity, it is time to find answers fast
After our comprehensive investigation, bmiMD receives a 8.1/10 rating
7f) and lacked neutralizing IgM and IgG antibodies against VSV-G glycoprotein (Fig